Original Source(s)
Related Content
Cancer Is Coming for Younger Adults — and the Field Isn’t Ready
The epidemiological tools built for midlife disease are straining to explain a generational shift
by Kerri Miller
April 7, 2026
-
3 min
FDA Approves New First-Line TNBC Regimen
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026
-
3 min
Cutaneous Rhabdomyosarcoma May Mask Melanoma
Molecular and epigenetic profiling suggested most tumors in a rare cutaneous sarcoma cohort were better classified as transdifferentiated melanoma.
April 28, 2026
-
3 min
